313 related articles for article (PubMed ID: 9865840)
21. Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis.
Cummings TJ; Provenzale JM; Hunter SB; Friedman AH; Klintworth GK; Bigner SH; McLendon RE
Acta Neuropathol; 2000 May; 99(5):563-70. PubMed ID: 10805102
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
Prayson RA; Mohan DS; Song P; Suh JH
Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
[TBL] [Abstract][Full Text] [Related]
23. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study.
Klein R; Roggendorf W
Acta Neuropathol; 2001 Mar; 101(3):245-8. PubMed ID: 11307624
[TBL] [Abstract][Full Text] [Related]
24. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas.
Abramovich CM; Prayson RA
Arch Pathol Lab Med; 1999 Sep; 123(9):793-800. PubMed ID: 10458826
[TBL] [Abstract][Full Text] [Related]
25. Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas.
Tihan T; Davis R; Elowitz E; DiCostanzo D; Moll U
Arch Pathol Lab Med; 2000 Jan; 124(1):108-13. PubMed ID: 10629140
[TBL] [Abstract][Full Text] [Related]
26. Pilocytic astrocytoma: a retrospective study of 32 cases.
Cyrine S; Sonia Z; Mounir T; Badderedine S; Kalthoum T; Hedi K; Moncef M
Clin Neurol Neurosurg; 2013 Aug; 115(8):1220-5. PubMed ID: 23265563
[TBL] [Abstract][Full Text] [Related]
27. Predictive factors for early symptomatic recurrence in pilocytic astrocytoma: does angiogenesis have a role to play?
Kurwale NS; Suri V; Suri A; Sarkar C; Gupta DK; Sharma BS; Mahapatra AK
J Clin Neurosci; 2011 Apr; 18(4):472-7. PubMed ID: 21292490
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
Schwimer CJ; Prayson RA
Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
[TBL] [Abstract][Full Text] [Related]
29. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
[TBL] [Abstract][Full Text] [Related]
30. Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas.
Krieger MD; Gonzalez-Gomez I; Levy ML; McComb JG
Pediatr Neurosurg; 1997 Jul; 27(1):1-11. PubMed ID: 9486830
[TBL] [Abstract][Full Text] [Related]
31. Adult Pilocytic Astrocytoma: An Institutional Series and Systematic Literature Review for Extent of Resection and Recurrence.
Bond KM; Hughes JD; Porter AL; Orina J; Fang S; Parney IF
World Neurosurg; 2018 Feb; 110():276-283. PubMed ID: 29180079
[TBL] [Abstract][Full Text] [Related]
32. Novel Surgical and Radiologic Risk Factors for Progression or Recurrence of Pediatric Pilocytic Astrocytoma.
Villanueva KG; Rea ND; Krieger MD
Pediatr Neurosurg; 2019; 54(6):375-385. PubMed ID: 31593969
[TBL] [Abstract][Full Text] [Related]
33. Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients.
Forsyth PA; Shaw EG; Scheithauer BW; O'Fallon JR; Layton DD; Katzmann JA
Cancer; 1993 Aug; 72(4):1335-42. PubMed ID: 8339223
[TBL] [Abstract][Full Text] [Related]
34. Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome.
Margraf LR; Gargan L; Butt Y; Raghunathan N; Bowers DC
Neuro Oncol; 2011 Jul; 13(7):767-74. PubMed ID: 21653594
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of cyclin A in astrocytic tumours.
Chakrabarty A; Bridges LR
Neuropathol Appl Neurobiol; 1998 Jun; 24(3):239-45. PubMed ID: 9717190
[TBL] [Abstract][Full Text] [Related]
36. MIB1 and p53 immunoreactivity in protoplasmic astrocytomas.
Prayson RA; Estes ML
Pathol Int; 1996 Nov; 46(11):862-6. PubMed ID: 8970195
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical examination of proliferative potentials and the expression of cell cycle-related proteins of intracranial chordomas.
Matsuno A; Sasaki T; Nagashima T; Matsuura R; Tanaka H; Hirakawa M; Murakami M; Kirino T
Hum Pathol; 1997 Jun; 28(6):714-9. PubMed ID: 9191006
[TBL] [Abstract][Full Text] [Related]
38. Infiltrative astrocytomas with granular cell features (granular cell astrocytomas): a study of histopathologic features, grading, and outcome.
Brat DJ; Scheithauer BW; Medina-Flores R; Rosenblum MK; Burger PC
Am J Surg Pathol; 2002 Jun; 26(6):750-7. PubMed ID: 12023579
[TBL] [Abstract][Full Text] [Related]
39. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.
Kim CH; Bak KH; Kim YS; Kim JM; Ko Y; Oh SJ; Kim KM; Hong EK
Surg Neurol; 2000 Sep; 54(3):235-40. PubMed ID: 11118570
[TBL] [Abstract][Full Text] [Related]
40. Correlation between MIB-1 staining indices and recurrence in low-grade astrocytomas.
Hoshi M; Yoshida K; Shimazaki K; Sasaki H; Otani M; Kawase T
Brain Tumor Pathol; 1997; 14(1):47-51. PubMed ID: 9384802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
